About
Female
Jean is a General Partner of Lightstone Ventures. She focuses on biopharmaceutical and medical device investments out of the firm’s Boston office, where she also serves as a General Partner of Advanced Technology Ventures (ATV). Her representative investments include Acceleron Pharma (NASDAQ: XLRN), Calithera Biosciences (NASDAQ: CALA), Cyteir Therapeutics, Disarm Therapeutics (acquired by Eli Lilly), Flex Pharma (NASDAQ: FLKS), Five Prime Therapeutics (NASDAQ: FPRX), Gemini Therapeutics, Hypnion (acquired by Eli Lilly), Locanabio Therapeutics, Portola Pharmaceuticals (NASDAQ: PTLA), Proteolix (acquired by Onyx Pharmaceuticals), Tizona Therapetics (acquired by Gilead), Verastem (NASDAQ: VSTM), and Zeltiq Aesthetics (NASDAQ: ZLTQ).
Experience
Advanced Technology Ventures
View →General Partner
31Menlo Park, California, United StatesFinance · Payments
Lightstone Ventures
View →General Partner
Finance · Financial Services
BancBoston Ventures
View →Member of the Board of Directors
31Boston, Massachusetts, United StatesConsulting · Public Relations
- Member of the Board of Directors · Acceleron Pharma2005 – present
- Board Member · Astria Therapeutics
- Member of the Board of Directors · Calithera Biosciences
- Board Of Director · Cyteir Therapeutics
- Board Of Director · Disarm Therapeutics
- Board Member · Gemini Therapeutics
- Member of the Board of Directors · Hydra Biosciences
- Member of the Board of Directors · Portola Pharmaceuticals
- Board Member · Thrasos
- Member of the Board of Directors · Zeltiq Aesthetics
Education
- University of Maine · BS, Biology– 1980
- Simmons University · MBA, unknown
People at Advanced Technology Ventures
Data from: crunchbase
